NCT00002326View on ClinicalTrials.gov

The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Adefovir

DRUG

Zidovudine

Trial Locations (1)

20892

Natl Cancer Institute, Bethesda

Sponsors

Lead Sponsor

Gilead Sciences

All Listed Sponsors

lead

Gilead Sciences

INDUSTRY